Mark E Saad
Director · 2 filings · Latest: Jun 8, 2026
Axsome Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AXSM | Mark E Saad | Director | Jun 8, 2026 | Option Exercise | — | 1,429 | — | 11,431 | |
AXSM | Saad Mark E | — | Dec 31, 2025 | Proposed Sale | $165.18 | 37,577 | $6.2M | — | |
AXSM | Saad Mark E | — | Sep 5, 2025 | Proposed Sale | $125.07 | 9,127 | $1.1M | — | |
AXSM | Saad Mark E | — | Sep 11, 2024 | Proposed Sale | $91.31 | 11,016 | $1.0M | — |